Oxford Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-40,000
| Closed | -$650K | – | 442 |
|
|
2024
Q2 | $650K | Sell |
40,000
-24,000
| -38% | -$390K | 0.63% | 38 |
|
|
2024
Q1 | $903K | Buy |
+64,000
| New | +$903K | 0.94% | 14 |
|
|
2020
Q1 | $106K | Sell |
11,829
-455,267
| -97% | -$4.08M | 0.01% | 139 |
|
|
2019
Q4 | $4.58M | Sell |
467,096
-280,537
| -38% | -$2.75M | 0.13% | 174 |
|
|
2019
Q3 | $5.14M | Buy |
+747,633
| New | +$5.14M | 0.12% | 192 |
|
|
2019
Q1 | – | Sell |
-185,841
| Closed | -$2.87M | – | 1963 |
|
|
2018
Q4 | $2.87M | Sell |
185,841
-81,912
| -31% | -$1.26M | 0.07% | 311 |
|
|
2018
Q3 | $5.75M | Buy |
267,753
+88,636
| +49% | +$1.9M | 0.12% | 189 |
|
|
2018
Q2 | $4.41M | Sell |
179,117
-107,078
| -37% | -$2.64M | 0.08% | 251 |
|
|
2018
Q1 | $4.89M | Buy |
+286,195
| New | +$4.89M | 0.1% | 196 |
|
|
2016
Q4 | – | Sell |
-224,434
| Closed | -$10.3M | – | 861 |
|
|
2016
Q3 | $10.3M | Buy |
224,434
+123,986
| +123% | +$5.7M | 0.32% | 66 |
|
|
2016
Q2 | $5.05M | Sell |
100,448
-28,720
| -22% | -$1.44M | 0.17% | 147 |
|
|
2016
Q1 | $6.91M | Sell |
129,168
-42,003
| -25% | -$2.25M | 0.2% | 113 |
|
|
2015
Q4 | $11.3M | Buy |
171,171
+132,187
| +339% | +$8.73M | 0.27% | 65 |
|
|
2015
Q3 | $2.2M | Buy |
38,984
+29,511
| +312% | +$1.67M | 0.07% | 272 |
|
|
2015
Q2 | $560K | Sell |
9,473
-20,543
| -68% | -$1.21M | 0.02% | 514 |
|
|
2015
Q1 | $1.87M | Sell |
30,016
-30,134
| -50% | -$1.88M | 0.05% | 376 |
|
|
2014
Q4 | $3.43M | Buy |
+60,150
| New | +$3.43M | 0.08% | 262 |
|
|
2014
Q3 | – | Sell |
-94,567
| Closed | -$4.96M | – | 755 |
|
|
2014
Q2 | $4.96M | Buy |
+94,567
| New | +$4.96M | 0.16% | 167 |
|
|
2014
Q1 | – | Sell |
-241,115
| Closed | -$9.66M | – | 765 |
|
|
2013
Q4 | $9.66M | Buy |
+241,115
| New | +$9.66M | 0.24% | 107 |
|
|
2013
Q3 | – | Sell |
-229,360
| Closed | -$8.99M | – | 895 |
|
|
2013
Q2 | $8.99M | Buy |
+229,360
| New | +$8.99M | 0.24% | 102 |
|